General Dynamics secures contract with Army medical division

General Dynamics will support the military’s R&D for vaccines, drugs and equipment.
General Dynamics will support the military’s R&D for vaccines, drugs and equipment. | Contributed photo

General Dynamics’ IT division recently attained a contract worth approximately $52 million with the U.S. Army’s medical division to assist with research and development for inoculation, medication and medical devices over the next five years.

The Virginia-based firm will lend operational, field-specific and logistical expertise for advancing the manufacturing of U.S. Army Medical Materiel Development Activity (USAMMDA) products at Fort Detrick in Frederick, Maryland. General Dynamics will also steer the division through FDA regulatory procedures to bring items to the market.

"General Dynamics has extensive experience delivering a combination of health, military and IT services," General Dynamics Information Technology’s Health and Civilian Solutions Senior Vice President Marcus Collier said. "We are committed to continuing our partnership with USAMMDA and assisting their mission of protecting and preserving the lives of warfighters."

The company will support the military’s R&D specifically for vaccines, drugs and equipment. General Dynamics has collaborated with the USAMMDA for over 25 years on a variety of tasks, from information technology, program supervision and training to regulatory, technical, medical and general scientific work.

General Dynamics’ information technology division provides “flexible, life cycle solutions” and services to the defense industry including cybersecurity, information systems, vehicle procurement, and mission support as well as health care solutions, according to its website.




Top